Product image of Buvidal (Buprenorphine) supplied by GNH India

Buvidal

Active Ingredient:
Buprenorphine
Origin:
EU

Buvidal (Buprenorphine)

Buvidal is a subcutaneous formulation of buprenorphine, used for opioid dependence treatment. This long-acting injection offers a convenient alternative to daily dosing.

Manufacturer / TM Owner

Camurus Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Buvidal is primarily used for the management of opioid dependence. It works by binding to opioid receptors in the brain, helping to reduce withdrawal symptoms and cravings. Buvidal is designed for subcutaneous use, providing a sustained release of buprenorphine over an extended period. This can simplify treatment regimens and improve adherence for those managing opioid dependence.

Side Effects

  • Common effects of Buvidal may include injection site reactions, such as redness, swelling, or itching. Some individuals may experience nausea, constipation, or headaches. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

  • Buvidal should be handled with care, ensuring proper storage and administration as directed. It is important to follow the prescribed dosage and administration schedule. Individuals with a history of allergic reactions to buprenorphine or similar medications should exercise caution. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

  • Buvidal may interact with other medications, including those that affect the central nervous system, such as sedatives or alcohol. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, certain medications that inhibit or induce liver enzymes may affect the metabolism of buprenorphine.

Frequently Asked Questions

Buvidal is used for the management of opioid dependence, providing a long-acting alternative to daily dosing.

Buvidal is administered via subcutaneous injection, typically by a healthcare professional.

Common side effects may include injection site reactions, nausea, constipation, and headaches.

Buvidal may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Buvidal is designed for extended release, typically administered every few weeks as prescribed by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Buprenorphine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT